235 related articles for article (PubMed ID: 10405747)
41. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation.
Hussain SM; Zondervan PE; IJzermans JN; Schalm SW; de Man RA; Krestin GP
Radiographics; 2002; 22(5):1023-36; discussion 1037-9. PubMed ID: 12235331
[TBL] [Abstract][Full Text] [Related]
42. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue.
Bhartia B; Ward J; Guthrie JA; Robinson PJ
AJR Am J Roentgenol; 2003 Mar; 180(3):577-84. PubMed ID: 12591657
[TBL] [Abstract][Full Text] [Related]
43. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations.
Kanematsu M; Semelka RC; Leonardou P; Mastropasqua M; Lee JK
J Magn Reson Imaging; 2003 Aug; 18(2):189-95. PubMed ID: 12884331
[TBL] [Abstract][Full Text] [Related]
44. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
Liu X; Xu YK; Huang QL; Wu YK
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
[TBL] [Abstract][Full Text] [Related]
45. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.
Kim JI; Lee JM; Choi JY; Kim YK; Kim SH; Lee JY; Han JK; Choi BI
Invest Radiol; 2008 Mar; 43(3):202-10. PubMed ID: 18301317
[TBL] [Abstract][Full Text] [Related]
46. Angiogenesis in hepatocellular nodules: correlation of MR imaging and vascular endothelial growth factor.
Kanematsu M; Semelka RC; Leonardou P; Mastropasqua M; Armao D; Vaidean G; Firat Z; Woosley JT
J Magn Reson Imaging; 2004 Sep; 20(3):426-34. PubMed ID: 15332250
[TBL] [Abstract][Full Text] [Related]
47. Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver.
Li RK; Palmer SL; Zeng MS; Qiang JW; Chen F; Rao SX; Chen LL; Dai YM
PLoS One; 2015; 10(11):e0142882. PubMed ID: 26605946
[TBL] [Abstract][Full Text] [Related]
48. Hepatic nodules in Budd-Chiari syndrome: imaging features.
Vilgrain V; Lewin M; Vons C; Denys A; Valla D; Flejou JF; Belghiti J; Menu Y
Radiology; 1999 Feb; 210(2):443-50. PubMed ID: 10207428
[TBL] [Abstract][Full Text] [Related]
49. Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma.
Kobayashi S; Matsui O; Kamura T; Yamamoto S; Yoneda N; Gabata T; Terayama N; Sanada J
J Comput Assist Tomogr; 2007; 31(4):557-63. PubMed ID: 17882031
[TBL] [Abstract][Full Text] [Related]
50. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S
Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218
[TBL] [Abstract][Full Text] [Related]
51. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).
Murakami T; Baron RL; Federle MP; Peterson MS; Oliver JH; Davis PL; Confer SR
Radiology; 1996 Feb; 198(2):567-72. PubMed ID: 8596867
[TBL] [Abstract][Full Text] [Related]
52. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
Park MJ; Kim YK; Lee MH; Lee JH
Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
[TBL] [Abstract][Full Text] [Related]
53. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
54. MR imaging in cirrhosis and hepatocellular carcinoma.
Barr DC; Hussain HK
Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):315-35. PubMed ID: 25086932
[TBL] [Abstract][Full Text] [Related]
55. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging.
Gandon Y; Guyader D; Heautot JF; Reda MI; Yaouanq J; Buhé T; Brissot P; Carsin M; Deugnier Y
Radiology; 1994 Nov; 193(2):533-8. PubMed ID: 7972774
[TBL] [Abstract][Full Text] [Related]
56. Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging--a case report.
Krinsky GA; Theise ND; Rofsky NM; Mizrachi H; Tepperman LW; Weinreb JC
Radiology; 1998 Nov; 209(2):461-4. PubMed ID: 9807574
[TBL] [Abstract][Full Text] [Related]
57. Focal manifestations of diffuse liver disease at MR imaging.
Mitchell DG
Radiology; 1992 Oct; 185(1):1-11. PubMed ID: 1523289
[TBL] [Abstract][Full Text] [Related]
58. Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imaging.
Siegelman ES; Mitchell DG; Rubin R; Hann HW; Kaplan KR; Steiner RM; Rao VM; Schuster SJ; Burk DL; Rifkin MD
Radiology; 1991 May; 179(2):361-6. PubMed ID: 2014275
[TBL] [Abstract][Full Text] [Related]
59. Hepatocellular carcinoma: MR imaging.
Itoh K; Nishimura K; Togashi K; Fujisawa I; Noma S; Minami S; Sagoh T; Nakano Y; Itoh H; Mori K
Radiology; 1987 Jul; 164(1):21-5. PubMed ID: 3035606
[TBL] [Abstract][Full Text] [Related]
60. Segmental iron deposition in the liver due to decreased intrahepatic portal perfusion: findings at MR imaging.
Kadoya M; Matsui O; Kitagawa K; Kawamori Y; Yoshikawa J; Gabata T; Miyayama S; Takashima T
Radiology; 1994 Dec; 193(3):671-6. PubMed ID: 7972806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
